Gallbladder cancer is a rare adenocarcinoma cancer that begins typically in the glandular cells that line the inner surface of the gallbladder, and if found in the early stages, has a good prognosis, yet it is difficult to detect early because it does not have any specific signs or symptoms. It is unclear what causes gallbladder cancer but cancer develops when healthy cells undergo mutations in their DNA, allowing uncontrolled cell growth in the gallbladder. Gallbladder cancer is more common in women, with risk increasing in age and with individuals who have gallstones. Treatments include surgery, chemotherapy, and radiation therapy. Unresectable gallbladder cancer occurs in stages III and IV where the cancer has spread to the tissues outside of the gallbladder and cannot be completely removed with surgery. Most individuals with gallbladder cancer have unresectable cancer.
Unresectable Gallbladder Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Unresectable Gallbladder Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 667 products for the study of Unresectable Gallbladder Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.